期刊文献+

血清可溶性CD14和肌酐在冠心病评估中的价值 被引量:3

Value of serum soluble CD14 and creatinine in evaluating coronary heart disease
原文传递
导出
摘要 目的探讨外周血清可溶性CD14(sCD14)和肌酐(Cr)在冠心病(CHD)患者病情评估中的价值。方法 CHD患者154例分为急性心肌梗死(A组,54例)、不稳定型心绞痛(B组,60例)和稳定型心绞痛(C组,40例)三组;冠状动脉造影术正常的50例患者作为对照(D组)。根据首次血清Cr浓度分为E组(106μmol/L≤Cr≤194μmol/L,82例)和F组(Cr<106μmol/L,72例)。乳胶比浊法、酶联免疫吸附法、氧化酶法分别测定并比较各组血清C反应蛋白(CRP)、sCD14和Cr水平。结果 A、B组血清CRP、sCD14和Cr浓度均高于C、D组,A组亦高于B组(P<0.05);C组Cr浓度高于D组(P<0.05)。E组血清CRP和sCD14浓度均高于F组(P<0.05)。血清sCD14、Cr与CRP呈正相关(r=0.717、0.623,P<0.01);血清sCD14与Cr呈正相关(r=0.568,P<0.01)。结论血清sCD14和Cr水平均能够反映CHD的严重程度,且与CHD,尤其是急性冠脉综合征可能存在密切联系的炎性机制。 Objective To explore the value of serum soluble CD14(sCD14) and creatinine(Cr) in evaluating coronary heart disease(CHD). Methods A total of 154 patients with CHD was divided into three groups of A(acute myocardial infarction, 54 cases), B(unstable angina pectoris, 60 cases) and C(stable angina pectoris, 40 cases). Fifty patients with normal coronary angiography served as normal controls(group D). According to the first serum Cr concentration, 154 patients with CHD were divided into group E(106μmol/L≤Cr≤194μmol/L,82cases) and group F(Cr〈106μmol/L,72 cases). Serum C reactive protein(CRP), sCD14 and Cr levels were measured by latex turbidimetry method, ELISA and oxidation enzyme method, respectively. Results Serum CRP, sCD14 and Cr levels in groups of A and B were higher than those in groups of C and D,which were higher in group A than those in group B(P〈0. 05). Serum Cr level was higher in group C than that in group D(P〈0. 05). Serum CRP and sCD14 levels were higher in group E than those in group F(P〈0. 05). Serum sCD14 and Cr levels were positively correlated with CRP(r=0. 717,0. 623, P(0. 01). Serum sCD14 was positively correlated with Cr(r=0. 568,P〈0. 01). Conclusion Serum sCD14 and Cr levels can reflect the severity of CHD, which are closely related to the inflammatory mechanism of CHD, especially in the patients with acute coronary syndrome.
出处 《江苏医药》 CAS 2015年第15期1780-1782,共3页 Jiangsu Medical Journal
基金 巴彦淖尔市科技计划项目(Y201317)
关键词 冠心病 可溶性CD14 肌酐 C反应蛋白 Coronary heart disease Soluble CD14 Creatinine C reactive protein
  • 相关文献

参考文献9

  • 1李剑,李勇,黄成磊,罗心平,施海明,朱蓉英,徐旭凌.估计的肾小球滤过率与传统冠心病危险因素相关性的比较研究[J].复旦学报(医学版),2009,36(1):46-52. 被引量:13
  • 2Wannamethee SG,Shaper AG,Lowe GD,et al.Renal function and cardiovascular mortality in elderly men:the role of inflammatory,procoagulant,and endothelial biomarkers[J].Eur Heart J,2006,27(24):2975-2981.
  • 3Hansson GK.Inflammation,atherosclerosis,and coronary artery disease[J].N Engl J Med,2005,352(16):1685-1695.
  • 4Lee JD,Kato K,Tobias PS,et al.Transfection of CD14 into70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide(LPS)and LPS binding protein[J].J Exp Med,1992,175(6):1697-1705.
  • 5Loppnow H,Stelter F,Schonbeck U,et al.Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14[J].Infect Immun,1995,63(3):1020-1026.
  • 6Lee WH,Lee Y,Jeong JO,et al.Activation of CD14 on circulating monocytes in patients with acute coronary syndrome[J].Int J Cardiol,2001,80(2-3):135-142.
  • 7Nunes JP,Faria Mdo S,Garcia JM,et al.Glomerular filtration rate and coronary artery disease burden in patients with acute coronary syndrome[J].Clin Cardiol,2007,30(9):464-468.
  • 8Anavekar NS,McMurray JJ,Velazquez EJ,et al.Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction[J].N Engl J Med,2004,351(13):1285-1295.
  • 9Luft FC.Renal disease as a risk factor for cardiovascular disease[J].Basic Res Cardiol,2000,95(Suppl 1):172-176.

二级参考文献24

  • 1Zannad F,Jakobsen A, Heroys J, et al. Cardiovascular high- risk patients-treat to protect, but whom? [J]. Medscape J Med, 2008,10 (Suppl) :S2.
  • 2Munmer P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States[J]. J Am Soc Nephrol,2002, 13 (3): 745 - 753.
  • 3Wannamethee SG, Shaper AG, Lowe GD,et al. Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers[J]. Eur Heart J ,2006,27(24):2 975 - 2 981.
  • 4Henry RM, Kostense PJ, Bos G,et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the hoorn study[J]. Kidney Int, 2002,62 (4) : 1 402 - 1 407.
  • 5Culleton BF, Larson MG, Wilson PW, et al. Cardiovascular disease and mortality in a community-based cohort with mild renalinsufficiency[J]. Kidney Int, 1999, 56 (6): 2 214 - 2 219.
  • 6Perrone RD,Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts[J].Clin Chem ,1992,38(10) :1 933 - 1 953.
  • 7Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Ann Intern Meal,2003,139(2) :137 - 147.
  • 8McCullough PA,Soman SS, Shah SS, et al. Risks associated with renal dysfunction in patients in the coronary care unit [J]. J Am Coll Cardiol,2000 ,36( 3 ) :679 - 684.
  • 9Dries DL, Exner DV, Domanski J, et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction [J]. J Am Coll Cardiol ,2000,35( 3 ) :681 - 689.
  • 10Best PJ,Lennon R, Ting HH, et aZ. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions[J]. J Am Coll Cardiol, 2002,39(7):1 113-1 119.

共引文献12

同被引文献22

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部